Johnson Pharmacare Complete Financial Statements
In FY2026, Johnson Pharmacare (JOHNPHARMA) reported revenue ₹0 Cr, net profit ₹-56 Cr and EPS ₹-1.01. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Analyse Johnson Pharmacare ownership structure to track promoter, FII and institutional holdings.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
JOHNPHARMA Revenue, Net Profit & EBITDA — Year-on-Year Growth
JOHNPHARMA YoY (March 2025 vs March 2026), net profit -5500.0%, EBITDA -5600.0%, expenses +5600.0%. For live price, earnings ratios and company overview, see Johnson Pharmacare screener.
JOHNPHARMA Income Statement — Revenue, EBITDA & Net Profit
Johnson Pharmacare revenue ₹0 Cr, EBITDA ₹-57 Cr, net profit ₹-56 Cr, EPS ₹-1.01 (2026). Also explore Johnson Pharmacare stock price data download to track price trends across different timeframes.
| Particulars | March 2026 | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 3 | 3 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
| Expenses | 57 | 1 | 0 | 4 | 3 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
| EBITDA | -57 | -1 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit Margin % | 0.00% | 0.00% | 0.00% | -53.00% | 4.00% | 0.00% | 0.00% | -1.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -56 | -1 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -56 | -1 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Earnings Per Share (₹) | -1.01 | -0.01 | 0.00 | -0.02 | 0.00 | 0.00 | -0.02 | 0.00 | -0.01 | -0.02 | -0.03 | -0.01 |
JOHNPHARMA Balance Sheet — Assets, Liabilities & Shareholders' Equity
JOHNPHARMA total assets ₹22 Cr, total equity ₹0 Cr, total liabilities ₹ Cr (2026).
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Total Assets | 22 | 58 | 60 | 60 | 60 | 60 | 59 | 60 | 60 | 59 | 59 | 60 |
| Current Assets | 2 | 1 | 0 | 0 | 1 | 6 | 5 | 5 | 4 | 4 | 22 | 4 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 42 | 46 | 46 | 54 | 52 | 52 | 53 | 54 | 54 | 8 | 0 |
| Other Assets | 0 | 16 | 14 | 14 | 6 | 7 | 7 | 7 | 6 | 5 | 51 | 60 |
| LIABILITIES | ||||||||||||
| Total Liabilities | ||||||||||||
| Current Liabilities | 21 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 |
| Non-Current Liabilities | ||||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||||
| Total Equity | 0 | 56 | 57 | 57 | 58 | 58 | 58 | 58 | 58 | 58 | 58 | 59 |
| Share Capital | 55 | 55 | 55 | 55 | 55 | 50 | 50 | 50 | 50 | 50 | 50 | 50 |
| Reserves & Surplus | -55 | 1 | 2 | 2 | 3 | 8 | 8 | 8 | 8 | 8 | 8 | 9 |
JOHNPHARMA Cash Flow Statement — Operating, Investing & Financing
Johnson Pharmacare operating cash flow ₹-2 Cr, investing ₹3 Cr, financing ₹-1 Cr, net cash flow ₹0 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -2 | 0 | 0 | 5 | 0 | 0 | -1 | -1 | 11 | -11 | 8 |
| Investing Activities | 3 | 0 | -1 | -5 | 0 | 1 | 1 | 0 | -11 | 11 | 10 |
| Financing Activities | -1 | 0 | 1 | 0 | 0 | -1 | 0 | 1 | 0 | 0 | 2 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21 |